InVivoMab anti-mouse CD28 BE0015-5-R025mg from Bio X Cell

Product Specs
ItemInVivoMab anti-mouse CD28
CompanyBio X Cell
Price $2,183.00Supplier Page View Company Product Page
Catalog NumberBE0015-5-R025mg
Quantity25 mg
ConcentrationLot-Specific
Conjugate/TagUnconjugated
FormatPBS, pH 7.0, Contains no stabilizers or preservatives, Liquid
Purity≥95% Determined by SDS-PAGE
ReactivityMouse
IsotypeArmenian Hamster IgG, κ
ClonePV-1
HostArmenian hamster
Antibody TypePrimary Antibody
ImmunogenC57BL/6 mouse T cell lymphoma EL-4 cells
NCBI Full Gene Nameintegrin beta 1 (fibronectin receptor beta)
NCBI Gene Aliases4633401G24Rik, CD29, Fnrb, Gm9863, gpIIa
ClonalityMonoclonal
Research AreaCancer Biology, Immune Checkpoint Protein, Immunology, CD Markers
StorageThe antibody solution should be stored at the stock concentration at 4°C. Do not freeze
Molecular Weight150 kDa
ModificationsNo
OriginUnited States

Specifications/Features

Endotoxin: ≤1EU/mg (≤0.001EU/µg), Determined by LAL gel clotting assay

Quantities Available: 1mg, 5mg, 25mg,50mg, 100mg, Additional Custom Sizing Available on bioxcell.com

Add to Compare List

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bioxcell.com

Company Profile

Website: bioxcell.com

(1) Identification of environmental factors that promote intestinal inflammationNatureNovember 1, 2022Sanmarco LM, Chao CC, Wang YC, Kenison JE, Li Z, Rone JM, Rejano-Gordillo CM, Polonio CM, Gutierrez-Vazquez C, Piester G, et al.Miltenyi) and activated with anti-CD3 (10 μg ml−1, BE0001-1-A005mg, BioXcell) and anti-CD28 (0.25 μg ml−1, BE0015-5-A005mg, BioXcell) antibodies in the presence of DMSO (vehicle) or propyzamide (2 μM). Cells were polarized

(2) Gut-licensed IFNγ⁺ NK cells drive LAMP1⁺TRAIL⁺ anti-inflammatory astrocytesNatureFebruary 1, 2021Sanmarco LM, Wheeler MA, Gutiérrez-Vázquez C, Polonio CM, Linnerbauer M, Pinho-Ribeiro FA, Li Z, Giovannoni F, Batterman KV, Scalisi G, et al.overnight with 10 μg ml−1 anti-CD3 (bioXcell, BE0001-1-A005mg) and 0.25 μg ml−1 anti-CD28 (bioXcell, BE0015-5-A005mg). For co-culture with EAE T cells, T cells were isolated from mice undergoing EAE at the peak of disease

(3) Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitorsEuropean journal of medicinal chemistryOctober 20, 2015Pallandre JR, Borg C, Rognan D, Boibessot T, Luzet V, Yesylevskyy S, Ramseyer C, Pudlo M.

(4) Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient miceMucosal immunologyMay 1, 2015Bertin S, Lozano-Ruiz B, Bachiller V, García-Martínez I, Herdman S, Zapater P, Francés R, Such J, Lee J, Raz E, et al.

(5) CRK proteins selectively regulate T cell migration into inflamed tissuesThe Journal of clinical investigationMarch 2, 2015Huang Y, Clarke F, Karimi M, Roy NH, Williamson EK, Okumura M, Mochizuki K, Chen EJ, Park TJ, Debes GF, et al.

(6) CXCL13 antibody for the treatment of autoimmune disordersBMC immunologyFebruary 12, 2015Klimatcheva E, Pandina T, Reilly C, Torno S, Bussler H, Scrivens M, Jonason A, Mallow C, Doherty M, Paris M, et al.

(7) The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4⁺ T cellsNature immunologyNovember 1, 2014Bertin S, Aoki-Nonaka Y, de Jong PR, Nohara LL, Xu H, Stanwood SR, Srikanth S, Lee J, To K, Abramson L, et al.

(8) The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cellsNature immunologyAugust 1, 2014Végran F, Berger H, Boidot R, Mignot G, Bruchard M, Dosset M, Chalmin F, Rébé C, Dérangère V, Ryffel B, et al.

(9) IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1Nature communicationsMay 6, 2014Heinemann C, Heink S, Petermann F, Vasanthakumar A, Rothhammer V, Doorduijn E, Mitsdoerffer M, Sie C, Prazeres da Costa O, Buch T, et al.

(10) SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growthCancer researchJune 15, 2013Berger H, Végran F, Chikh M, Gilardi F, Ladoire S, Bugaut H, Mignot G, Chalmin F, Bruchard M, Derangère V, et al.

(11) Ezrin and moesin are required for efficient T cell adhesion and homing to lymphoid organsPloS oneJanuary 1, 2013Chen EJ, Shaffer MH, Williamson EK, Huang Y, Burkhardt JK.

(12) IL-9 as a mediator of Th17-driven inflammatory diseaseThe Journal of experimental medicineAugust 3, 2009Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, Schreiner B, Coyle AJ, Kasper LH, Noelle RJ.

Be the First to Write a Review!

InVivoMab anti-mouse CD28

InVivoMab anti-mouse CD28

InVivoMab anti-mouse CD28

InVivoMab anti-mouse CD28 from Bio X Cell

Description

Specifications/Features

Bio X Cell

Citations (12)

Reviews

InVivoMab anti-mouse CD28 from Bio X Cell

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map